News

Burlington Stores Ready to Share Q4 and FY2024 Results Soon

Burlington Stores Ready to Share Q4 and FY2024 Results Soon

Burlington Stores Planning for Earnings Report

Burlington Stores, Inc. is poised to release its fourth quarter and fiscal year 2024 earnings results ahead of the opening of the U.S. stock markets. This significant event will take place on an upcoming Thursday in March 2025, marking an important moment for investors and stakeholders alike.

Conference Call Details

On the day of the earnings announcement, the Company will host a conference call at 8:30 a.m. ET. This call will provide insights into the latest financial performance and strategic initiatives. Participants can join via a toll-free U.S. dial-in number or an international line, ensuring accessibility for all interested parties.

How to Join the Conference Call

Investors can dial in using the U.S. toll-free number or the designated international number. Those who wish to join should be prepared with the provided passcode to streamline the access process, enhancing the experience for all participants.

Replay Options Available

For those unable to attend the live call, Burlington Stores will offer a replay available shortly after the conclusion of the event. This feature will allow stakeholders to catch up on the discussions and key takeaways, ensuring no one misses out on critical information.

Accessing the Replay

The replay can be accessed through specific numbers designated for U.S. and international audiences, and it will remain available for a certain period. This option reflects Burlington's commitment to transparency and shareholder engagement.

Communicating with Stakeholders

Burlington Stores continues to utilize various channels to communicate essential updates about the Company. These include SEC filings, official press releases, public calls, and webcasts. This proactive approach ensures that all relevant parties remain informed about significant developments and opportunities.

Engagement Through Social Media

The Company encourages stakeholders to visit its main website for detailed information and to follow its social media channels for real-time updates. These platforms are valuable resources for news regarding new brands, services, and corporate initiatives.

About Burlington Stores

Burlington Stores, Inc., a nationally recognized off-price retailer known for offering branded apparel and home goods at reasonable prices, reported impressive net sales exceeding $9.7 billion in Fiscal 2023. With a strong presence across the United States, including 1,103 stores, Burlington caters to a diverse customer base, providing significant savings on a wide array of products.

Company Growth and Expansion

The Company is continuously focused on expanding its footprint and enhancing its product offerings, ensuring customers have access to the latest fashion trends at discounted prices. Committed to high-quality merchandise and customer satisfaction, Burlington Stores remains a trusted name in retail.

Investor Relations Contacts

For additional inquiries, interested parties can reach out to the investor relations team, led by David J. Glick and Daniel Delrosario at 855-973-8445. They welcome questions and feedback from investors and analysts alike.

Frequently Asked Questions

When will Burlington Stores announce its earnings results?

Burlington Stores will release its earnings before the U.S. market opens on a Thursday in March 2025.

How can I participate in the conference call?

Participants can dial in using the U.S. toll-free or international number provided on the company's official communication.

Is there a replay of the conference call available?

Yes, a replay will be available shortly after the conference call, allowing stakeholders to listen at their convenience.

How does Burlington communicate important updates?

Burlington communicates through SEC filings, press releases, public calls, webcasts, as well as its official website and social media channels.

Who can I contact for investor relations?

Investors can contact David J. Glick or Daniel Delrosario at 855-973-8445 for any inquiries regarding investor relations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles